epithalon wirkung Epitalon Meet one of our favorite

Dihexa is considered safe in moderate doses

It mimics endogenous GLP-1, enhancing glucose-dependent insulin secretion, decreasing glucagon secretion, and significantly reducing appetite and energy intake, which leads to clinically meaningful weight loss

The standard cycle is four to eight weeks of daily dosing followed by a two to four week rest period

If transitioning from subcutaneous to nasal administration, start at your established injectable dose and adjust based on response rather than assuming a specific conversion ratio

Dihexa is not a conventional peptide but a peptidomimetic a small molecule (~504 Da) designed to mimic peptide binding activity while resisting enzymatic degradation

GHK-Cu/Epitalon is given as a subcutaneous injection, often in cycles, on a provider-determined schedule